Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Brain atrophy in relapsing multiple sclerosis: relationship to relapses, EDSS, and treatment with interferon beta-1a.

Rudick RA, Fisher E, Lee JC, Duda JT, Simon J.

Mult Scler. 2000 Dec;6(6):365-72.

PMID:
11212130
[PubMed - indexed for MEDLINE]
2.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
[PubMed - indexed for MEDLINE]
3.

What is new in the treatment of multiple sclerosis?

Weinstock-Guttman B, Jacobs LD.

Drugs. 2000 Mar;59(3):401-10. Review.

PMID:
10776827
[PubMed - indexed for MEDLINE]
4.

Management of worsening multiple sclerosis with mitoxantrone: a review.

Fox EJ.

Clin Ther. 2006 Apr;28(4):461-74. Review.

PMID:
16750460
[PubMed - indexed for MEDLINE]
5.

Interferon-beta-1b: a review of its use in relapsing-remitting and secondary progressive multiple sclerosis.

McCormack PL, Scott LJ.

CNS Drugs. 2004;18(8):521-46. Review.

PMID:
15182221
[PubMed - indexed for MEDLINE]
6.

Spotlight on Interferon-beta-1b in relapsing-remitting and secondary progressive multiple sclerosis.

McCormack PL, Scott LJ.

BioDrugs. 2004;18(5):343-7. Review.

PMID:
15377176
[PubMed - indexed for MEDLINE]
7.

PRISMS: the story of a pivotal clinical trial series in multiple sclerosis.

Cohen BA, Rivera VM.

Curr Med Res Opin. 2010 Apr;26(4):827-38. doi: 10.1185/03007991003604018. Review. Erratum in: Curr Med Res Opin. 2010 Aug;26(8):1826. Dosage error in article text.

PMID:
20121658
[PubMed - indexed for MEDLINE]
8.

Subcutaneous recombinant interferon-β-1a (Rebif®): a review of its use in the treatment of relapsing multiple sclerosis.

Sanford M, Lyseng-Williamson KA.

Drugs. 2011 Oct 1;71(14):1865-91. doi: 10.2165/11207540-000000000-00000. Review.

PMID:
21942977
[PubMed - indexed for MEDLINE]
9.

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, Lai HM, Rocca MA, Moseley IF, Miller DH.

Ann Neurol. 1998 Mar;43(3):332-9. Review.

PMID:
9506550
[PubMed - indexed for MEDLINE]
10.

Interferon beta treatment for multiple sclerosis: persisting questions.

Goodkin DE.

Mult Scler. 1996 Jul;1(6):321-4. Review.

PMID:
9345408
[PubMed - indexed for MEDLINE]
11.

Interferon beta 1a.

Pozzilli C, Koudriavtseva T.

Baillieres Clin Neurol. 1997 Oct;6(3):481-93. Review.

PMID:
10101585
[PubMed - indexed for MEDLINE]
12.

Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.

Brown JW, Coles AJ.

Drug Des Devel Ther. 2013;7:131-8. doi: 10.2147/DDDT.S32687. Epub 2013 Mar 6. Review.

PMID:
23494602
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Early treatment trials with interferon beta in multiple sclerosis.

Panitch HS.

Mult Scler. 1995;1 Suppl 1:S17-21. Review.

PMID:
9345392
[PubMed - indexed for MEDLINE]
14.

MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS).

Barkhof F.

Mult Scler. 1999 Aug;5(4):283-6. Review.

PMID:
10467389
[PubMed - indexed for MEDLINE]
15.

[Aggressive multiple sclerosis. Definition and specific therapeutic indication].

Edan G.

Presse Med. 2004 Feb 14;33(3):187-91; discussion 192. Review. French.

PMID:
15029034
[PubMed - indexed for MEDLINE]
16.

Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis.

Munschauer FE 3rd, Stuart WH.

Clin Ther. 1997 Sep-Oct;19(5):868-82. Review.

PMID:
9385476
[PubMed - indexed for MEDLINE]
17.

Disease-modifying agents in the treatment of multiple sclerosis: a review of long-term outcomes.

Katrych O, Simone TM, Azad S, Mousa SA.

CNS Neurol Disord Drug Targets. 2009 Dec;8(6):512-9. Review.

PMID:
19811446
[PubMed - indexed for MEDLINE]
18.

Interferon beta-1a in relapsing-remitting multiple sclerosis.

Blumhardt L.

Hosp Med. 1999 Mar;60(3):192-5. Review.

PMID:
10476242
[PubMed - indexed for MEDLINE]
19.

Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis.

Bhardwaj S, Coleman CI, Sobieraj DM.

Am J Health Syst Pharm. 2012 Sep 1;69(17):1494-9. doi: 10.2146/ajhp110675. Review.

PMID:
22899744
[PubMed - indexed for MEDLINE]
20.

Newer versus older treatments for relapsing-remitting multiple sclerosis.

Weinstock-Guttman B, Cohen JA.

Drug Saf. 1996 Feb;14(2):121-30. Review.

PMID:
8852526
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk